These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 21907588

  • 1. miR-196a2 C allele is a low-penetrant risk factor for cancer development.
    Qiu LX, Wang Y, Xia ZG, Xi B, Mao C, Wang JL, Wang BY, Lv FF, Wu XH, Hu LQ.
    Cytokine; 2011 Dec; 56(3):589-92. PubMed ID: 21907588
    [Abstract] [Full Text] [Related]

  • 2. MTHFR C677T polymorphism associated with breast cancer susceptibility: a meta-analysis involving 15,260 cases and 20,411 controls.
    Zhang J, Qiu LX, Wang ZH, Wu XH, Liu XJ, Wang BY, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):549-55. PubMed ID: 20143151
    [Abstract] [Full Text] [Related]

  • 3. The association between common genetic variant of microRNA-146a and cancer susceptibility.
    Qiu LX, He J, Wang MY, Zhang RX, Shi TY, Zhu ML, Mao C, Sun S, Lv FF, Zheng CL, Zhu XD.
    Cytokine; 2011 Dec; 56(3):695-8. PubMed ID: 21978540
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. XPD Lys751Gln polymorphism and breast cancer susceptibility: a meta-analysis involving 28,709 subjects.
    Qiu LX, Yao L, Zhang J, Zhu XD, Zhao XM, Xue K, Mao C, Chen B, Zhan P, Yuan H, Hu XC.
    Breast Cancer Res Treat; 2010 Nov; 124(1):229-35. PubMed ID: 20204500
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. TGFB1 T29C polymorphism and breast cancer risk: a meta-analysis based on 10,417 cases and 11,455 controls.
    Gu D, Zhuang L, Huang H, Cao P, Wang D, Tang J, Chen J.
    Breast Cancer Res Treat; 2010 Oct; 123(3):857-61. PubMed ID: 20157775
    [Abstract] [Full Text] [Related]

  • 10. BRCA2 N372H polymorphism and breast cancer susceptibility: a meta-analysis involving 44,903 subjects.
    Qiu LX, Yao L, Xue K, Zhang J, Mao C, Chen B, Zhan P, Yuan H, Hu XC.
    Breast Cancer Res Treat; 2010 Sep; 123(2):487-90. PubMed ID: 20135345
    [Abstract] [Full Text] [Related]

  • 11. The association between two polymorphisms of eNOS and breast cancer risk: a meta-analysis.
    Yao L, Fang F, Zhong Y, Yu L.
    Breast Cancer Res Treat; 2010 Nov; 124(1):223-7. PubMed ID: 20204503
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Meta-analysis of the association between a polymorphism in microRNA-196a2 and susceptibility to colorectal cancer.
    Shi KQ, Lin Z, Li DW, Fang YX, Gao J, Deng ZJ, Chen L, Li GL, Wu JM, Tang KF.
    Onkologie; 2013 Nov; 36(10):560-5. PubMed ID: 24107909
    [Abstract] [Full Text] [Related]

  • 14. TGFbeta1 T29C polymorphism and cancer risk: a meta-analysis based on 40 case-control studies.
    Wei BB, Xi B, Wang R, Bai JM, Chang JK, Zhang YY, Yoneda R, Su JT, Hua LX.
    Cancer Genet Cytogenet; 2010 Jan 01; 196(1):68-75. PubMed ID: 19963138
    [Abstract] [Full Text] [Related]

  • 15. Current evidences on XPC polymorphisms and breast cancer susceptibility: a meta-analysis.
    Zheng W, Cong XF, Cai WH, Yang S, Mao C, Zou HW.
    Breast Cancer Res Treat; 2011 Aug 01; 128(3):811-5. PubMed ID: 21318603
    [Abstract] [Full Text] [Related]

  • 16. Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects.
    Yao L, Yu X, Yu L.
    Breast Cancer Res Treat; 2010 Jul 01; 122(2):503-7. PubMed ID: 20052535
    [Abstract] [Full Text] [Related]

  • 17. Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects.
    Qiu LX, Yao L, Mao C, Yu KD, Zhan P, Chen B, Yuan H, Zhang J, Xue K, Hu XC.
    Breast Cancer Res Treat; 2010 Jul 01; 122(2):521-5. PubMed ID: 20054636
    [Abstract] [Full Text] [Related]

  • 18. XRCC3 5'-UTR and IVS5-14 polymorphisms and breast cancer susceptibility: a meta-analysis.
    Qiu LX, Mao C, Yao L, Yu KD, Zhan P, Chen B, Liu HG, Yuan H, Zhang J, Xue K, Hu XC.
    Breast Cancer Res Treat; 2010 Jul 01; 122(2):489-93. PubMed ID: 20049524
    [Abstract] [Full Text] [Related]

  • 19. Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects.
    Qiu LX, Yao L, Mao C, Chen B, Zhan P, Yuan H, Xue K, Zhang J, Hu XC.
    Breast Cancer Res Treat; 2010 Sep 01; 123(2):543-7. PubMed ID: 20143154
    [Abstract] [Full Text] [Related]

  • 20. The association between two polymorphisms in pre-miRNAs and breast cancer risk: a meta-analysis.
    Gao LB, Bai P, Pan XM, Jia J, Li LJ, Liang WB, Tang M, Zhang LS, Wei YG, Zhang L.
    Breast Cancer Res Treat; 2011 Jan 01; 125(2):571-4. PubMed ID: 20640596
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.